Tone mix
Week by week 52 weeks
Share of Alkermes Inc. plc's 208 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Oct 5, 2026 · tone +100Why Baird Sees Promising Growth Potential in Alkermes plc (ALKS)+91
- Week of Mar 23, 2026 · tone +100Alkermes (NASDAQ:ALKS) Upgraded to Strong-Buy at Truist Financial+86
- Week of Aug 10, 2026 · tone +97Could Alkermes plc (ALKS) Stock Rebound After Investors Look Beyond Near-Term Profit Pressure?+71
- Week of Mar 16, 2026 · tone +83Alkermes CEO Pops Calls 2026 a "Really Exciting Year" as Orexin Agonists Near Narcolepsy Launch+70
- Week of Jun 22, 2026 · tone +98Micron To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday - Alkermes (NASDAQ:ALKS), Biog+65
- Week of May 11, 2026 · tone +95Alkermes Gains Momentum After Sleep Disorder Trial Clears Key Hurdles - Alkermes (NASDAQ:ALKS)+53
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Alkermes Inc. plc in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 2 | 0 |
| Last 30 sessions | 14 | +25 |
| Last 90 sessions | 43 | +17 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Tuesday, October 27, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.dailypolitical.com · 1 outletOpus Genetics (NASDAQ:IRD) vs. Alkermes (NASDAQ:ALKS) Financial AnalysisNeutral
- www.tickerreport.com · 1 outletHead to Head Review: Alkermes (NASDAQ:ALKS) and Opus Genetics (NASDAQ:IRD)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Opus Genetics (NASDAQ:IRD) vs. Alkermes (NASDAQ:ALKS) Financial Analysis | www.dailypolitical.com | 1 | Neutral |
| Head to Head Review: Alkermes (NASDAQ:ALKS) and Opus Genetics (NASDAQ:IRD) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 20, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletFinancial Survey: INmune Bio (NASDAQ:INMB) vs. Alkermes (NASDAQ:ALKS)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Financial Survey: INmune Bio (NASDAQ:INMB) vs. Alkermes (NASDAQ:ALKS) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 19, 2026
2 headlines, average tone +50: 1 positive, 1 neutral and 0 negative. Showing all 2.
- seekingalpha.com · 1 outletAlkermes stock reinstated Buy at Truist (ALKS:NASDAQ)Positive
- www.tickerreport.com · 1 outletTraders Buy High Volume of Put Options on Alkermes (NASDAQ:ALKS)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Alkermes stock reinstated Buy at Truist (ALKS:NASDAQ) | seekingalpha.com | 1 | Positive |
| Traders Buy High Volume of Put Options on Alkermes (NASDAQ:ALKS) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 13, 2026
2 headlines, average tone +35: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.finanznachrichten.de · 1 outletAlkermes plc: Alkermes to Present New Data on Alixorexton and LUMRYZ (sodium oxybate) at Sleep Europe 2026, Underscoring Leadership in Sleep Medicine ResearchPositive
- www.tickerreport.com · 1 outletReviewing Alkermes (NASDAQ:ALKS) and uniQure (NASDAQ:QURE)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Alkermes plc: Alkermes to Present New Data on Alixorexton and LUMRYZ (sodium oxybate) at Sleep Europe 2026, Underscoring Leadership in Sleep Medicine Research | www.finanznachrichten.de | 1 | Positive |
| Reviewing Alkermes (NASDAQ:ALKS) and uniQure (NASDAQ:QURE) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 6, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.insidermonkey.com · 1 outletWhy Baird Sees Promising Growth Potential in Alkermes plc (ALKS)Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Why Baird Sees Promising Growth Potential in Alkermes plc (ALKS) | www.insidermonkey.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Alkermes Inc. plc, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.